2012
DOI: 10.1016/s0140-6736(12)61528-1
|View full text |Cite
|
Sign up to set email alerts
|

Academic output of 9 years of EU investment into health research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(28 citation statements)
references
References 0 publications
0
28
0
Order By: Relevance
“…4 We believe this type of follow-up should be routine, to minimise creation of 'research waste' (i.e., research that stops at publication and does not benefit the populations). 28,29 We also call upon journals and researchers to operationalise this process and track their publications for policy impact. 30 We had a 100% response rate, and clarification was sought whenever responses were ambiguous, thus achieving participant validation.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…4 We believe this type of follow-up should be routine, to minimise creation of 'research waste' (i.e., research that stops at publication and does not benefit the populations). 28,29 We also call upon journals and researchers to operationalise this process and track their publications for policy impact. 30 We had a 100% response rate, and clarification was sought whenever responses were ambiguous, thus achieving participant validation.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…We focussed our research on the healthcare domain due to the great applicability and growth of nanotechnology in medicine (Gabellieri and Frima 2011), which has been highly prioritized over the past European Framework Programmes (European Commission 2010; Galsworthy et al 2012).…”
Section: Sample Selection and Data Collectionmentioning
confidence: 99%
“…5 For example, research investment by the European Commission (EC) amounted to 55.8 billion euros in its 2007-2013 Framework Programme. 13 This was dedicated to 'upstream' development of basic science and technology, including clinical trials. For such huge investments to translate into benefits for communities, 'downstream' absorption and application of the knowledge generated within health systems is essential.…”
Section: Benefits Of Supporting Open-access Publications For Operatiomentioning
confidence: 99%